Holen Sie sich die Stockscreener-App
25.90
10.92%
2.55
Vorhandelsmarkt:
26.03
0.13
+0.50%
Schlusskurs vom Vortag:
$23.35
Offen:
$21.6
24-Stunden-Volumen:
313.59K
Relative Volume:
0.70
Marktkapitalisierung:
$12.81B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.58M
KGV:
-3,597.22
EPS:
-0.0072
Netto-Cashflow:
$-767.30K
1W Leistung:
-0.77%
1M Leistung:
-6.55%
6M Leistung:
+90.86%
1J Leistung:
+530.17%
1-Tages-Spanne:
$20.00
$29.01
1-Wochen-Bereich:
$20.00
$29.01
52-Wochen-Spanne:
$3.99
$950.00
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Compare RGC vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGC
Regencell Bioscience Holdings Ltd
|
25.90 | 11.55B | 0 | -3.58M | -767.30K | -0.0072 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.07 | 56.49B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
122.36 | 51.26B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.26 | 45.79B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.50 | 36.16B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
529.17 | 20.96B | 3.13B | 1.27B | 1.12B | 26.39 |
Regencell Bioscience Holdings Ltd Aktie (RGC) Neueste Nachrichten
Regencell Bioscience (NASDAQ:RGC) Shares Gap DownTime to Sell? - MarketBeat
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now - The Motley Fool
DOJ Probe Puts Regencell Bioscience Finances And Investor Outlook Under Strain - simplywall.st
Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential (NASDAQ:RGC) - Seeking Alpha
A Look At Regencell Bioscience Holdings (RGC) Valuation After Department Of Justice Investigation News - Yahoo Finance
How Investors Are Reacting To Regencell Bioscience Holdings (RGC) DOJ Probe And Earnings Misses - Sahm
Volume Recap: Is Regencell Bioscience Holdings Limited stock a smart retirement pickJuly 2025 Macro Moves & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Earnings Report: Whats The Andersons Incs historical return2025 Institutional Moves & Weekly Watchlist of Top Performers - baoquankhu1.vn
Regencell Bioscience Holdings Limited (NASDAQ:RGC) Sees Significant Drop in Short Interest - MarketBeat
Regencell Bioscience (NASDAQ:RGC) Shares Down 13.1%Should You Sell? - MarketBeat
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need - Yahoo Finance
Aug Retail: Can Regencell Bioscience Holdings Limited grow without external funding2025 Market Overview & Verified Technical Trade Signals - baoquankhu1.vn
RGC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Chinese Stocks To Watch Now – February 22nd - Defense World
RGC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Chinese Stocks To Watch NowFebruary 22nd - MarketBeat
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Promising Chinese Stocks To Watch TodayFebruary 21st - MarketBeat
Regencell Bioscience (NASDAQ:RGC) Stock Price Down 6.6%Should You Sell? - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Mystery $33 billion Chinese medical fortune collapses in days - MSN
Regencell Bioscience Holdings (RGC) Valuation After Insider Lock Up Extension And Rapid Share Price Momentum - Sahm
Regencell Bioscience Holdings Limited (NASDAQ:RGC) Short Interest Down 16.3% in January - MarketBeat
What is Regencell Bioscience Holdings Limited’s valuation compared to sectorTrade Risk Summary & AI Powered Buy and Sell Recommendations - mfd.ru
Does Regencell Bioscience (RGC) Extending Insider Lock-Ups Recast Its Management Alignment Story? - simplywall.st
RGC PE Ratio & Valuation, Is RGC Overvalued - Intellectia AI
Regencell Bioscience Holdings Ltd. Trade Ideas — NASDAQ:RGC - TradingView
Regencell wins extension to insider lock-ups (RGC:NASDAQ) - Seeking Alpha
Softer-Than-Expected Inflation Sparks Rally In These 10 Stocks - Benzinga
Regencell Bioscience (NASDAQ:RGC) Trading Up 8.9%Still a Buy? - MarketBeat
What technical charts say about Regencell Bioscience Holdings Limited stockJuly 2025 Patterns & Low Drawdown Trading Techniques - mfd.ru
Regencell Bioscience (NASDAQ:RGC) Shares Gap UpStill a Buy? - MarketBeat
Aug Levels: Is Regencell Bioscience Holdings Limited stock heavily shortedMarket Trend Review & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Pre-market Movers: WINT, ME, UBX, RGC... - RTTNews
Regencell Bioscience (NASDAQ:RGC) Trading Down 10.1%Here's Why - MarketBeat
Update Recap: What are the risks of holding Regencell Bioscience Holdings LimitedGDP Growth & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Volatility Watch: Will Regencell Bioscience Holdings Limited outperform its industry peers2025 Major Catalysts & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Largest borrow rate increases among liquid names - TipRanks
Regencell Bioscience (NASDAQ:RGC) Trading Up 12.6%Should You Buy? - MarketBeat
Regencell Bioscience Holdings Limited (NASDAQ:RGC) Short Interest Down 28.1% in January - MarketBeat
Best Chinese Stocks To Watch TodayJanuary 8th - MarketBeat
Chinese Stocks Worth WatchingJanuary 30th - MarketBeat
A Look At Regencell Bioscience Holdings (RGC) Valuation After Market Value Surges Despite Ongoing Challenges - simplywall.st
Regencell Bioscience (NASDAQ:RGC) Stock Price Down 7.4%Here's What Happened - MarketBeat
Aug EndMonth: Can Regencell Bioscience Holdings Limited grow without external fundingMarket Activity Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Regencell Bioscience Holdings (RGC) Is Up 6.5% After Valuation Surges Despite DOJ Probe And No Revenue - simplywall.st
HCA Healthcare Posts Upbeat Q4 Earnings, Joins Redwire, General Motors And Other Big Stocks Moving Higher On Monday - Benzinga
Regencell’s $14 Billion Mirage: Herbal Autism Bets Fuel Meme Mania - WebProNews
This $14 Billion Meme Stock Says It Is Developing a Herbal Remedy for Autism - WSJ
Revolution Medicines, Erasca And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Finanzdaten der Regencell Bioscience Holdings Ltd-Aktie (RGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):